Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Application

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 11 > >>
EC Number Application Commentary Reference
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144diagnostics GnT-III expression levels are elevated in high-grade serous ovarian carcinoma tissues and correlate with reduced survival 759483
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144medicine apart from GnT-III overexpression, engineering of GnT-III localization is a versatile tool to modulate the biological activities of antibodies relevant for their therapeutic application 672706
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144medicine enzyme activity in extrahepatic bile duct carcinoma is increased 3fold compared to mean enzyme activity values, resulting in increased bisecting-GlcNAc on the glycans of glycoproteins in cancer tissues and a 201 kDa bile glycoprotein 658862
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144medicine enzyme activity is elevated in serum of 60 out of 86 patients with liver cirrhosis, and of 86 out of 91 patients with chronic hepatitis 658860
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144medicine enzyme activity is elevated in three choriocarcinoma cell lines compared to normal placenta. Activity in JEG-3 cells is 27 times higher than normal 658863
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144medicine the majority of N-glycans of a recombinant antibody produced in Nicotiana tabacum expressing GnT-III is bisected and devoid of paucimannosidic structures. This might improve the efficacy of therapeutic antibodies produced in the transgenic plants 673888
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144medicine therapeutic potential of inhibiting GnT-III as a treatment for controlling epithelial ovarian carcinoma (EOC) growth and recurrence 759483
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144synthesis introduction of human N-acetylglucosaminyltransferase gene into tobacco plants leads to highly efficient synthesis of bisected N-glycans. The majority of N-glycans of an antibody produced in a plant expressing GnT-III is also bisected. This might improve the efficacy of therapeutic antibodies produced in this type of transgenic plant 673888
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144synthesis overexpression of enzyme in human hepatoma cells fails to reduce branch formation of N-glycans, coexpression of caveolin-1 leads to a dramatic decrease in the extent of branching with no enhancement of enzyme activity 659223
Display the word mapDisplay the reaction diagram Show all sequences 2.4.1.144synthesis RC12 cells, apheochromocytoma cell line, transfected with enzyme gene, result in suppression of neurite outgrowth induced by costimulation of epidermal growth factor and integrins. Epidermal growth factor receptor-mediated ERK-activation is blocked in transfectants. Epidermal growth factor receptor of transfectants is modified by bisecting GlcNAc in its N-glycan structures 658847
Results 1 - 10 of 11 > >>